Abstract:Epidemiologic and clinical features of Kawasaki Disease (KD) strongly support an infectious etiology. KD is worldwide, most prominently in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility among Asian populations. In Hawaii, KD rates are 20-fold higher in Japanese ethnics than in Caucasians, intermediate in other ethnicities. The age distribution of KD, highest in children < 2 yo, lower in those < 6 months, is compatible with infection by a ubiquitous agent resulting in increasing immunity with age and with transplacental immunity, as with some classic viruses. The primarily winter-spring KD seasonality and well-documented Japanese epidemics with wave-like spread also support an infectious trigger. We hypothesize KD pathogenesis involves an RNA virus that usually causes asymptomatic infection but KD in a subset of genetically predisposed children. CD8 T cells, oligoclonal IgA, and upregulation of cytotoxic T cell and interferon pathway genes in the coronaries in fatal KD also support a viral etiology. Cytoplasmic inclusion bodies in ciliated bronchial epithelium identified by monoclonal antibodies made from oligoclonal IgA heavy chains also supports a viral etiology. Recent availability of "second generation" antibodies from KD peripheral blood plasmablasts may identify a specific viral antigen. Thus, we propose an unidentified ("new") RNA virus infects bronchial epithelium usually causing asymptomatic infection but KD in a subset of genetically predisposed children. The agent persists in inclusion bodies, with intermittent respiratory shedding, entering the bloodstream via macrophages targeting coronaries. Antigen-specific IgA plasma cells and CD8 T cells respond but coronaries can be damaged. IVIG may include antibody against the agent. Post infection, 97-99% of KD patients are immune to the agent, protected against recurrence. The agent can spread either from those with asymptomatic primary infection in winter-spring or from a previously infected contact who intermittently sheds the agent.

Research Advances in the Pathogenesis of Familial Kawasaki Disease

Regulatory T cells and Kawasaki disease

Progress in etiology and pathophysiology of Kawasaki disease

Clinical Features of Kawasaki Disease in Children with an Atypical Age of Onset

Study Progress of Coronary Artery Damage in Kawasaki Disease

Insights Into Coronary Artery Lesions in Kawasaki Disease

In vitro study status of Kawasaki disease

Meta-analysis of Risk Factors Associated with Atherosclerosis in Patients with Kawasaki Disease

Research Progress in Diagnosis and Treatment of Coronary Artery Lesions in Kawasaki Disease

Research Progress of Gene Polymorphism Related with Kawasaki Disease

Kawasaki Disease: An update on Genetics and Pathophysiology

The Epidemiology and Pathogenesis of Kawasaki Disease

Lkawasaki Disease: Global Burden and Genetic Background

Research Advances in the Treatment of Kawasaki Disease

Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

The global epidemiology of Kawasaki disease: Review and future perspectives

The Clinical Diagnosis and Management of Kawasaki Disease: a Review and Update

Epidemiology, Etiology, and Management of Kawasaki Disease: State of the Art

Kawasaki disease: pathophysiology and insights from mouse models

Kawasaki Disease and Coronary Artery Involvement: A Narrative Review

Advances in research of the relationship between adhesion molecules and pathogenesis of Kawasaki disease